Healthcare Professionals
Sprint Quattro
Defibrillator Lead for Tachyarrhythmia Management
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Healthcare Professionals
Defibrillator Lead for Tachyarrhythmia Management
Proven performance didn't happen by chance.
From lead design to active product monitoring, intentional choices and proactive steps were taken to ensure the reliability of the Sprint Quattro™ lead portfolio.
6935 |
DF-1 |
Single |
Active |
6935M |
DF4 |
Single |
Active |
6947 |
DF-1 |
Dual |
Active |
6947M |
DF4 |
Dual |
Active |
6946M |
DF4 |
Dual |
Passive |
Purposeful design decisions were made to produce a lead that lasts.
From the asymmetrical design to the material selection, the Sprint Quattro defibrillator lead was designed for reliability and tested in a variety of different ways to withstand in vivo conditions.
Sprint Quattro Secure™ 6947 lead shows a 94% lead survival rate at 14 years when measured by active, clinical monitoring.1
Specific lengths of the Sprint Quattro lead portfolio are approved for use in the MR environment. Patients with a Sprint Quattro MRI SureScan lead, coupled with a Medtronic SureScan cardiac device, are able to safely undergo an MRI scan when MR conditions for use are met.
A complete SureScan system is required for use in the MR environment, which includes a Medtronic SureScan device connected to Medtronic SureScan leads.
DF4 Models:
DF-1 Models:
MDT CRHF Product Performance eSource. Sprint Quattro 6947. Data as of October 2018. http://wwwp.medtronic.com/productperformance/model/6947-sprint-quattro-secure.html
Important Safety Information
Surgical complications such as cardiac perforation may occur and care must be taken when placing and positioning a cardiac lead.